Literature DB >> 7861910

Molgramostim to treat SS-sickle cell leg ulcers.

R C Pieters, R A Rojer, A W Saleh, A E Saleh, A J Duits.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861910

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

Review 2.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 3.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

4.  Local granulocyte-macrophage colony-stimulating factor improves incisional wound healing in adriamycin-treated rats.

Authors:  Mehmet Ali Gulcelik; Soykan Dinc; Meral Dinc; Erdinc Yenidogan; Huseyin Ustun; Nurten Renda; Haluk Alagol
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.

Authors:  Aslihan Turhan; Linnea A Weiss; Narla Mohandas; Barry S Coller; Paul S Frenette
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

Review 6.  Interventions for treating leg ulcers in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Jennifer M Knight-Madden; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2021-01-09

7.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 8.  A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Authors:  Igor A Altman; Raymond E Kleinfelder; John G Quigley; William J Ennis; Caterina P Minniti
Journal:  Int Wound J       Date:  2015-11-04       Impact factor: 3.315

9.  Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Authors:  Pashtoon Murtaza Kasi; Mrinal M Patnaik; Prema P Peethambaram
Journal:  Case Rep Hematol       Date:  2013-12-11

Review 10.  Interventions for treating leg ulcers in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Jennifer M Knight-Madden; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.